Eli Lilly Alzheimer’s Drug Fails Trial – Wall Street Journal

Wall Street Journal

Eli Lilly Alzheimer's Drug Fails Trial
Wall Street Journal
Alzheimer's is a progressive form of dementia that causes memory, thinking and behavioral problems with symptoms worsening as someone ages. Phase 3 clinical trials are typically the last phase before a drug seeks approval from the Food and Drug ...
Hopes for new Alzheimer's drug dashedBBC News
Lilly's solanezumab flunks late-stage study in Alzheimer's-related dementia; shares down 14% premarket; Biogen ...Seeking Alpha
Eli Lilly Shares Plunge as Alzheimer's Trial Fails to Achieve GoalsMorningstar.com
CNBC -Fox News
all 67 news articles »